INBS INTELLIGENT BIO SOLUTIONS INC Capital Structure Changes 8-K Filing 2024 - Stock Offering Intelligent Bio Solutions Inc. disclosed initial results from its Pharmacokinetic study for FDA submission and raised approximately $250,802 from stock sales under an At The Market Offering Agreement.Get access to all SEC 8-K filings of the INTELLIGENT BIO SOLUTIONS INC